Myqorzo’s Balance Sheet Meets Its Biggest Catalyst
With $1.7B in cash and a Q4 sNDA plan, Cytokinetics just validated a major untreated corner of HCM.
With $1.7B in cash and a Q4 sNDA plan, Cytokinetics just validated a major untreated corner of HCM.
SpaceX's $100 billion vertical-integration bet is a masterclass in founder-scale capital allocation. The question is whether the business behind it…
Ibotta returned to growth a quarter early. The bear case is still alive inside the numbers.
The Treasury buyback surprise, $7.93T in cash, and a yield curve that just broke its own rules.
Washington is refunding more in tariffs than it collects. Gold is a quiet beneficiary.
The U.S. has deployed $26.7 billion across chips, AI labs, quantum, and rare earths. The portfolio has no public address.
AI agent requests on Cloudflare's network grew 1,700% year-over-year. The monetization rails are just going live.
One quarter does not fix the North America problem.
Q2 earnings hit Tuesday. One segment number decides everything.
Brent posted its biggest monthly gain since March. Exxon, Chevron, and Shell earned a combined $404 million in profit per…